TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) is pleased to announce that its previously announced proposed investment transaction (the “Transaction”) with The Global South S.A.S., as outlined in the management information circular (the “Circular”) dated October 9, 2025, has been approved by the Company’s minority shareholders at the Company’s Special Meeting of Shareholders held on November 12th, 2025. The Transac ...